- Report
- February 2024
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 130 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 115 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- July 2025
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2505EUR$2,789USD£2,140GBP
- Report
- May 2024
- 136 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- May 2024
- 134 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- May 2025
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- July 2024
- 110 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- June 2025
- 206 Pages
Global
From €2245EUR$2,500USD£1,918GBP
- Report
- January 2025
- 144 Pages
Global
From €3548EUR$3,950USD£3,031GBP
- Report
- November 2023
- 140 Pages
Global
From €3997EUR$4,450USD£3,414GBP
- Report
- January 2024
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- July 2023
- 128 Pages
North America
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2025
- 83 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- October 2022
- 216 Pages
Middle East
From €3099EUR$3,450USD£2,647GBP
- Report
- December 2021
- 191 Pages
Global
From €3997EUR$4,450USD£3,414GBP
- Report
- May 2025
- 91 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- February 2025
- 130 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- December 2024
Saudi Arabia
From €1662EUR$1,850USD£1,419GBP

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery.
Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage.
Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases.
Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more